Generated by AI
McKesson Corporation is a healthcare services company that supports the flow of medicines, supplies, and related solutions across the healthcare system. The company operates through North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions, serving pharmacies, health systems, physician practices, post-acute care providers, and other care settings. Its pharmaceutical distribution business supplies branded, generic, specialty, biosimilar, and over-the-counter products, while its medical-surgical operations provide clinical supplies, logistics, and equipment support. McKesson also offers technology-enabled services that help healthcare organizations manage prescriptions, practice operations, and patient care workflows. Through its broad distribution network and service platforms, McKesson plays a central role in connecting manufacturers, providers, and pharmacies across the U.S. and internationally.
Website6555 State Highway 161
Irving, TX, 75039
United States
The latest articles about MCK.
The largest of America's three big drug wholesalers has outperformed the market this year, but is trading at a discount to its five-year median multiple.
Summary of Aug 25's posts. Generated by AI.
Summary of Feb 5's posts. Generated by AI.
McKesson's capital returns remain robust with a $5B 2027 buyback plan, low leverage, and dividend increases. See why I rate MCK stock as Hold. Read my analysis.
Summary of May 7's posts. Generated by AI.
Summary of Jan 30's posts. Generated by AI.
Investors talking about MCK also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.